0.00Open0.00Pre Close0 Volume0 Open Interest55.00Strike Price0.00Turnover326.00%IV-281.41%PremiumMay 16, 2025Expiry Date40.58Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9028Delta0.0160Gamma0.35Leverage Ratio-0.0406Theta-0.0186Rho-0.32Eff Leverage0.0060Vega
Keros Therapeutics Stock Discussion
Keros Eyes Potential Sale: Board Weighs Strategic Options Amid Investor Interest
Clinical Trial Success: KER-065 Hits All Safety Targets, Shows Promise for DMD Treatment
No comment yet